SCHEMBL7169484

SCHEMBL7169484

COC(=O)CC(N)c1ccc(OC(F)(F)F)cc1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
POLB P06746 1/20 0.45
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
EPHX2 P34913 1/20 0.44
L3MBTL1 Q9Y468 2/20 0.43
EPHX1 P07099 2/20 0.42
MRGPRX4 Q96LA9 1/20 0.41
HPGD P15428 1/20 0.41
HRH3 Q9Y5N1 2/20 0.40
KDM4E B2RXH2 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
GPR139 Q6DWJ6 1/20 0.40
HDAC3 O15379 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC2 Q92769 1/20 0.40
ACACB O00763 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3997626 0.96 KIF11 (0.46) ALDH1A1POLBMEN1KMT2ASMN1; SMN2
SCHEMBL12900637 0.84 ALDH1A1 (0.47) ALDH1A1POLBMEN1KMT2ASMN1; SMN2
SCHEMBL24037024 0.83 KMT2A (0.45) KMT2ASMN1; SMN2L3MBTL1EPHX1MRGPRX4
SCHEMBL5371011 0.83 EPHX1 (0.46) ALDH1A1KMT2ASMN1; SMN2EPHX2EPHX1
SCHEMBL28114756 0.83 EPHX1 (0.46) ALDH1A1EPHX2EPHX1HRH3
SCHEMBL7235148 0.83 EPHX1 (0.46) ALDH1A1KMT2ASMN1; SMN2EPHX2EPHX1
SCHEMBL2294181 0.83 CYP1A2 (0.54) ALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL5692076 0.82 LDHA (0.42) ALDH1A1
SCHEMBL25624108 0.82 LDHA (0.42) ALDH1A1
Hydrochloric Acid SCHEMBL16563786 0.82 EPHX1 (0.45) ALDH1A1EPHX2EPHX1HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6576637-B1 Such as 3-(4-methyl-3-nitrophenyl)-3-(2-(4-(pyridin-2-yl-amino)butyryl amino)acetylamino)propionic acid; thrombosis, heart infarct, coronary heart diseases, arteriosclerosis, inflammations, MERCK PATENT GMBH (DE) 2003-06-10 US disclosed
EP-1153014-A2 BETA-ALANINE DERIVATIVES MERCK PATENT GmbH (DE) 2001-11-14 EP disclosed
WO-2000048996-A2 β-ALANINE DERIVATIVES MERCK PATENT GMBH (DE) 2000-08-24 WO disclosed